1. Home
  2. ENTX vs FNWB Comparison

ENTX vs FNWB Comparison

Compare ENTX & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.15

Market Cap

50.9M

Sector

Health Care

ML Signal

HOLD

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.66

Market Cap

82.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTX
FNWB
Founded
2010
1923
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
50.9M
82.0M
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
ENTX
FNWB
Price
$1.15
$9.66
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$10.00
$13.50
AVG Volume (30 Days)
188.6K
46.2K
Earning Date
05-08-2026
04-23-2026
Dividend Yield
N/A
0.72%
EPS Growth
N/A
36.00
EPS
0.25
N/A
Revenue
$42,000.00
$176,000.00
Revenue This Year
N/A
$19.24
Revenue Next Year
N/A
$8.90
P/E Ratio
$4.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.91
$7.05
52 Week High
$3.22
$10.98

Technical Indicators

Market Signals
Indicator
ENTX
FNWB
Relative Strength Index (RSI) 48.30 74.39
Support Level $1.17 $9.26
Resistance Level $1.61 $10.21
Average True Range (ATR) 0.16 0.29
MACD 0.02 0.19
Stochastic Oscillator 60.42 100.00

Price Performance

Historical Comparison
ENTX
FNWB

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

Share on Social Networks: